Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DY7Q1O
|
|||
| Drug Name |
EPI-7386
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-9: 185] | Phase 1 | [1] | |
| Company |
ESSA Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04421222) Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer (EPI-7386). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of ESSA Pharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.